We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+15.22%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
+$148M
Cap. Flow
+$27M
Cap. Flow %
2.23%
Top 10 Hldgs %
38.39%
Holding
516
New
39
Increased
143
Reduced
266
Closed
39

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.89M
2
BABA icon
Alibaba
BABA
+$4.05M
3
SLV icon
iShares Silver Trust
SLV
+$4M
4
FUTU icon
Futu Holdings
FUTU
+$3.28M
5
AVGO icon
Broadcom
AVGO
+$3.25M

Top Sells

Rank Stock Value
1
SAP icon
SAP
SAP
+$2.28M
2
TPR icon
Tapestry
TPR
+$2.13M
3
ABT icon
Abbott
ABT
+$2.05M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.05M
5
TMUS icon
T-Mobile US
TMUS
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 39.61%
2 Healthcare 20.82%
3 Communication Services 12.95%
4 Consumer Discretionary 11.61%
5 Consumer Staples 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
326
Zymeworks
ZYME
$1.77B
$225K 0.02%
13,176
-820
-6% -$11.7K
RAPP
327
Rapport Therapeutics
RAPP
$2.29B
$220K 0.02%
7,398
+68
+0.9% +$1.21K
AMPH icon
328
Amphastar Pharmaceuticals
AMPH
$850M
$217K 0.02%
8,150
-1,318
-14% -$34K
TRML
329
DELISTED
Tourmaline Bio
TRML
$215K 0.02%
4,503
-656
-13% -$18.2K
GRFS
330
Grifois
GRFS
$5.4B
$213K 0.02%
21,384
-3,118
-13% -$31.2K
CVAC
331
DELISTED
CureVac
CVAC
$213K 0.02%
39,466
-5,756
-13% -$31.1K
ELVN icon
332
Enliven Therapeutics
ELVN
$4.24B
$213K 0.02%
10,383
+528
+5% +$10.6K
AMLX icon
333
Amylyx Pharmaceuticals
AMLX
$2.6B
$212K 0.02%
15,630
-2,274
-13% -$21.4K
DVAX
334
DELISTED
Dynavax Technologies
DVAX
$204K 0.02%
20,555
-3,563
-15% -$37.1K
PCRX icon
335
Pacira BioSciences
PCRX
$945M
$203K 0.02%
7,876
-1,424
-15% -$35K
INVA icon
336
Innoviva
INVA
$1.5B
$202K 0.02%
11,047
-1,561
-12% -$30.4K
PRAX icon
337
Praxis Precision Medicines
PRAX
$10.8B
$196K 0.02%
3,689
-402
-10% -$19.5K
TRVI icon
338
Trevi Therapeutics
TRVI
$2.53B
$195K 0.02%
21,346
+911
+4% +$6.83K
COLL icon
339
Collegium Pharmaceutical
COLL
$834M
$193K 0.02%
5,522
-934
-14% -$32.5K
NIO icon
340
NIO
NIO
$11.4B
$191K 0.02%
+25,000
New +$135K
SYRE icon
341
Spyre Therapeutics
SYRE
$9.18B
$177K 0.01%
10,587
-1,535
-13% -$25K
SPRY icon
342
ARS Pharmaceuticals
SPRY
$601M
$174K 0.01%
17,323
-2,403
-12% -$34.5K
PGEN icon
343
Precigen
PGEN
$2.45B
$172K 0.01%
52,230
-7,056
-12% -$19.9K
PRME icon
344
Prime Medicine
PRME
$580M
$170K 0.01%
30,650
+4,280
+16% +$17.4K
TNGX icon
345
Tango Therapeutics
TNGX
$4.31B
$164K 0.01%
19,502
-2,269
-10% -$15.4K
URGN icon
346
UroGen Pharma
URGN
$2.39B
$162K 0.01%
8,109
-1,152
-12% -$20.7K
SANA icon
347
Sana Biotechnology
SANA
$1.13B
$161K 0.01%
45,347
+45
+0.1% +$163
RLAY icon
348
Relay Therapeutics
RLAY
$4.4B
$158K 0.01%
30,221
-4,213
-12% -$16.1K
DFTX
349
Definium Therapeutics
DFTX
$5.68B
$157K 0.01%
13,337
-1,838
-12% -$17.1K
TSHA icon
350
Taysha Gene Therapies
TSHA
$2.05B
$156K 0.01%
47,817
-4,710
-9% -$13.3K
12 13
14
15 16

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q3 2025 Portfolio in Review

As of Q3 2025, China Universal Asset Management Company held 516 positions worth $1.21B, up 14% from $1.06B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

China Universal Asset Management Company's Q3 2025 filing shows 39 new, 143 increased, 266 reduced and 39 closed positions. Its largest new stake was Alibaba: 30,923 shares worth $5.53M. The largest sale was SAP, an estimated $2.28M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Communication Services.

  • China Universal Asset Management Company's largest Q3 2025 buy was Alibaba: 30,923 shares worth $5.53M.
  • China Universal Asset Management Company added most to NVIDIA in Q3 2025, an estimated $6.89M increase.
  • China Universal Asset Management Company's biggest Q3 2025 reduction was SAP, cutting an estimated $2.28M.
  • China Universal Asset Management Company fully exited Tapestry in Q3 2025, selling an estimated $2.13M.
  • China Universal Asset Management Company's ten largest holdings make up 38% of its $1.21B portfolio in Q3 2025.
  • China Universal Asset Management Company opened 39 new positions and closed 39 in Q3 2025.
  • China Universal Asset Management Company's portfolio value rose 14% quarter-over-quarter to $1.21B.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.